Characteristics of peripheral blood cells in patients with chronic renal failure at Thai Nguyen Central General Hospital

  • Nguyen Thi Ngoc Ha Thai Nguyen University of Medicine and Pharmacy
  • Tran Dieu Linh Thai Nguyen University of Medicine and Pharmacy
  • Le Dieu Ngan Thai Nguyen University of Medicine and Pharmacy
  • Sam Thi Yen Nhi Thai Nguyen University of Medicine and Pharmacy
  • Trinh Ha My Thai Nguyen University of Medicine and Pharmacy

Main Article Content

Keywords

Chronic kidney disease, anemia, Peripheral Blood Cells

Abstract

Objective: To describe the characteristics of peripheral blood cells and analyze factors associated with changes in peripheral blood cell parameters among patients with chronic kidney disease (CKD) treated at Thai Nguyen Central General Hospital. Subject and method: A cross-sectional descriptive study was conducted on 116 patients with CKD. Hematological indices (RBC, HGB, HCT, MCV, MCH, MCHC, WBC, PLT), biochemical parameters (total protein, albumin, creatinine, urea, serum iron, and ferritin), and CKD stages were collected and analyzed to determine their relationships. Results: The mean age was 65.7 ± 13.9 years, with 72.4% aged ≥ 60 years. Anemia was present in 65.5% of patients, including 46.6% with moderate and 6.9% with severe anemia. Mean values of HGB (111.6 ± 24.3g/L), HCT (33.2 ± 7.4%), and RBC (3.88 ± 0.87T/L) were below normal reference ranges. Red cell indices - MCV (86.9 ± 8.6fL), MCH (29.0 ± 3.6pg), and MCHC (331.2 ± 32.1g/L) - were mostly within normal limits, indicating normocytic-normochromic anemia. HGB, HCT, and RBC levels were significantly lower in CKD stages IV - V compared with stages I–III (p<0.001), while MCV, MCH, MCHC, WBC, and PLT showed no significant differences. The severity of anemia correlated negatively with serum creatinine (r = -0.495) and positively with serum albumin (r = 0.379), suggesting that both progressive renal impairment and protein-energy wasting contribute to the pathogenesis of anemia. Conclusion: Anemia is a common and progressive complication of CKD, predominantly normocytic-normochromic, reflecting reduced erythropoietin production. Both declining renal function and malnutrition are associated with disease progression. Regular monitoring of HGB, albumin, and creatinine is essential for early detection and management of anemia in CKD patients.

Article Details

References

1. Bikbov B, Purcell CA, Levey AS et al (2020) Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395(10225): 709-733.
2. Levin A, Tonelli M, Bonventre J et al (2017) Epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol 13(3): 173-185.
3. Glassock RJ, Warnock DG, Delanaye P. Chronic kidney disease: definition, classification, and prognosis. Am J Kidney Dis 77(3): 368-379.
4. KDIGO 2023 Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int Suppl. 13(1): 1-150.
5. Stanifer JW, Muiru A, Jafar TH, Patel UD (2016) Chronic kidney disease in low- and middle-income countries: Prevalence, outcomes, and challenges. Lancet 387(10015): 1976-1988.
6. Sofue T, Nakayama M, Tanaka M et al (2020) Prevalence and characteristics of anemia in chronic kidney disease: A Japanese multicenter study. BMC Nephrol 21: 420.
7. Locatelli F, Bárány P, Covic A et al (2023) Anemia management in chronic kidney disease: Recent advances and future perspectives. Clin Kidney J. 16(2): 315-324.
8. Pham Quoc Hung et al (2023) Characteristics of Anemia in Patients Undergoing Hemodialysis in Vietnam. Vietnamese Journal of Medicine. 525(1): 56-64.
9. World Health Organization (2021) Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO.
10. Taderegew MM et al (2023) Anemia and associated factors among patients with chronic kidney disease in Africa: a multicenter cross-sectional study. Front Med 10: 1122341.
11. Kovesdy CP et al (2020) Pathogenesis and management of anemia in chronic kidney disease. Nat Rev Nephrol 16(12): 753-769.
12. Yamamoto T, Matsuda M, Ueda S et al (2025) Ferritin and iron metabolism in chronic kidney disease: diagnostic and clinical implications. Kidney Res Clin Pract 44(1): 22-31.